
Natural Capsules Ltd is Rated Strong Sell
2026-05-19 10:10:22Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 May 2026, providing investors with the latest insights into its performance and outlook.
Read More
Natural Capsules Ltd is Rated Strong Sell
2026-05-08 10:10:22Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 08 May 2026, providing investors with the latest comprehensive view of the company’s position.
Read More
Natural Capsules Ltd is Rated Strong Sell
2026-04-27 10:10:25Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 27 April 2026, providing investors with the latest insights into its performance and outlook.
Read More
Natural Capsules Ltd is Rated Strong Sell
2026-04-16 10:10:16Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 April 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read More
Natural Capsules Ltd is Rated Strong Sell
2026-03-25 10:10:30Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
03-Jun-2026 | Source : BSEPursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of transcript of Conference Call held on Tuesday June 02 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
02-Jun-2026 | Source : BSEPursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Audio recording of Conference Call held on Tuesday June 02 2026 is available on the website of the Company.
Corrigendum To The Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations 2015 Dated May 27 2026.
01-Jun-2026 | Source : BSEThis has reference to our intimation under regulation 30(9) of SEBI (LODR) Regulation 2015 submitted to the Stock Exchange on May 27 2026 regarding the outcome of the Board Meeting of Material Unlisted Subsidiary (i.e. Natural Biogenex Private Limited) dealing the approval of the Right Issue. We wish to inform the exchange that due to a Typographical /Clerical error the total number of Equity Shares for the right issue was in inadvertently mentioned as 1111200 instead of 1111205.
Corporate Actions
No Upcoming Board Meetings
Natural Capsules Ltd has declared 10% dividend, ex-date: 20 Jul 23
No Splits history available
No Bonus history available
Natural Capsules Ltd has announced 1:2 rights issue, ex-date: 11 Nov 21
